Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Amador Bioscience Closes Acquisition of Ann Arbor Pharmacometrics Group.

Document Cited in Related
Vincent

MANews-(C)2009-2021

US-based translational sciences and clinical pharmacology CRO Amador Bioscience has completed the acquisition of Michigan, US-based pharmacometrics consulting firm Ann Arbor Pharmacometrics Group, the company said.

Combined with A2PG, Amador Bioscience will become a one-stop global translational science and clinical pharmacology CRO supporting nonclinical, early- and late-stage clinical development.

The company's services encompass advanced modeling and simulation, statistical programming, noncompartmental analysis, laboratory services, translational medicine, early clinical development, and clinical pharmacology trials.

As A2PG CEO and CSO of Amador Bioscience, Dr. Chapel will lead global expansion of clinical pharmacology business. Under her leadership, the consolidated team will continue to provide high-quality services under tight timelines.

In addition, through collaboration with local universities and associations, Dr. Chapel and her team will develop the next generation of clinical pharmacologists and pharmacometricians in the US, EU, and China.

Amador Bioscience, a partner for successful new drug development, provides global-standard translational sciences and clinical pharmacology services to clients ranging from...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT